Journal of the Royal College of Physicians of Edinburgh最新文献_第4页

Why do doctors use AI in healthcare? 为什么医生在医疗保健中使用人工智能？

IF 1.1

Journal of the Royal College of Physicians of Edinburgh Pub Date : 2025-03-01 Epub Date: 2024-12-11 DOI: 10.1177/14782715241306146

Abeera Junaid, Tamsin Adhiyaman, Nithin Fernando Edwin, Vedamurthy Adhiyaman

引用次数: 0

A rare presentation of neurofibromatosis mimicking leprosy. 罕见的神经纤维瘤病，类似麻风病。

IF 1.1

Journal of the Royal College of Physicians of Edinburgh Pub Date : 2025-03-01 Epub Date: 2025-01-17 DOI: 10.1177/14782715241313420

Sonika Garg, Arpita Nibedita Rout, Chandra Sekhar Sirka, Bevan Priyadharshan

引用次数: 0

Do low-risk patients really need follow-up after a pulmonary embolism? 低危患者在肺栓塞后真的需要随访吗？

IF 1.1

Journal of the Royal College of Physicians of Edinburgh Pub Date : 2025-03-01 Epub Date: 2025-01-08 DOI: 10.1177/14782715241311959

Lesley Alexander, Susan Burnie, Catherine Rossiter, Chris Isles

{"title":"Do low-risk patients really need follow-up after a pulmonary embolism?","authors":"Lesley Alexander, Susan Burnie, Catherine Rossiter, Chris Isles","doi":"10.1177/14782715241311959","DOIUrl":"10.1177/14782715241311959","url":null,"abstract":"Background: The British Thoracic Society recommend that pulmonary embolism (PE) patients with low-risk Pulmonary Embolism Severity Index (PESI) scores are considered for outpatient (OP) management, in settings where robust pathways for follow-up and monitoring exist.Methods: Retrospective cohort study. We reviewed the electronic records of 109 consecutive PE patients considered appropriate for OP management. Primary outcomes were the incidence of recurrent venous thromboembolism, major bleeding, mortality at 1 year and evidence of chronic thromboembolic pulmonary hypertension (CTEPH).Results: Low-risk PESI scores (I-II) were recorded in 78 (72%) patients, with higher scores a consequence of age and comorbidity rather than haemodynamic instability. There was a low rate of adverse outcomes despite a lack of formal follow up for most patients. There was no evidence of CTEPH in 34 patients who underwent echocardiography.Conclusion: Our analysis challenges the need for robust follow-up pathways for all patients with pulmonary embolism.","PeriodicalId":46606,"journal":{"name":"Journal of the Royal College of Physicians of Edinburgh","volume":" ","pages":"14-18"},"PeriodicalIF":1.1,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142956726","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Cutaneous larva migrans outside the tropics - A clue to global warming? 皮肤幼虫迁徙到热带以外——全球变暖的线索？

IF 1.1

Journal of the Royal College of Physicians of Edinburgh Pub Date : 2025-03-01 Epub Date: 2024-12-27 DOI: 10.1177/14782715241310288

David Bernal-Bello, Pedro Gallego-Torrero, Alejandro Morales-Ortega

引用次数: 0

Corridor care: Everywhere and anywhere. 走廊关怀：无处不在，无处不在。

IF 1.1

Journal of the Royal College of Physicians of Edinburgh Pub Date : 2025-03-01 Epub Date: 2025-02-10 DOI: 10.1177/14782715251319951

Clare Bostock

引用次数: 0

Features in this issue. 本文档介绍的特性。

IF 1.1

Journal of the Royal College of Physicians of Edinburgh Pub Date : 2025-03-01 Epub Date: 2025-02-28 DOI: 10.1177/14782715251325577

Graeme P Currie

引用次数: 0

Delirium assessment, management and barriers to effective care across Scotland: A secondary analysis of survey data from World Delirium Awareness Day 2023. 苏格兰全境谵妄评估、管理和有效护理障碍：对2023年世界谵妄意识日调查数据的二次分析

IF 1.1

Journal of the Royal College of Physicians of Edinburgh Pub Date : 2025-03-01 Epub Date: 2024-11-29 DOI: 10.1177/14782715241301486

Fariha Naeem, Rose S Penfold, Roy L Soiza, Rebecca Von Haken, Heidi Lindroth, Keibun Liu, Peter Nydhal, Terry J Quinn

{"title":"Delirium assessment, management and barriers to effective care across Scotland: A secondary analysis of survey data from World Delirium Awareness Day 2023.","authors":"Fariha Naeem, Rose S Penfold, Roy L Soiza, Rebecca Von Haken, Heidi Lindroth, Keibun Liu, Peter Nydhal, Terry J Quinn","doi":"10.1177/14782715241301486","DOIUrl":"10.1177/14782715241301486","url":null,"abstract":"Introduction: Delirium is a common, severe neuropsychiatric syndrome in hospitalised older adults. We evaluated use of validated delirium assessment tools, adherence to national guidelines and prevalence and management of delirium across Scotland, identifying barriers to effective care.Methods: Secondary analysis of national survey data, collected by participating clinicians on World Delirium Awareness Day (15 March 2023).Results: Among 120 responses (3,257 patients), the 4AT was the most frequently used assessment tool (75%), while 14% of units reported using clinical judgement alone. The delirium assessment rate was 74%, with a prevalence of 22% at 8 am. Management protocols varied, with frequent routine non-pharmacological interventions including pain management (88%), hydration (87%) and open family visiting (80%). Barriers to delirium care included insufficient staffing and training.Conclusion: While many hospital settings follow national delirium guidelines, some still rely on clinical judgement for assessment, with variability in management protocols and practices. We have highlighted key barriers to effective delirium care in Scotland.","PeriodicalId":46606,"journal":{"name":"Journal of the Royal College of Physicians of Edinburgh","volume":" ","pages":"6-13"},"PeriodicalIF":1.1,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142751580","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Dementia after stroke-risk prediction and management. 卒中后痴呆的风险预测和管理。

IF 1.1

Journal of the Royal College of Physicians of Edinburgh Pub Date : 2025-03-01 Epub Date: 2024-12-25 DOI: 10.1177/14782715241308365

Marni James, Emily Ball, Eugene Yee Hing Tang, Gillian Mead

引用次数: 0

Less than full-time training and future needs. 少于全日制培训及未来需要。

IF 1.1

Journal of the Royal College of Physicians of Edinburgh Pub Date : 2025-03-01 Epub Date: 2025-01-24 DOI: 10.1177/14782715251314568

Noor Jawad, Ali Jawad

引用次数: 0

Low-dose methotrexate in Rheumatology: A reinvented drug. 低剂量甲氨蝶呤在风湿病学中的应用：一种重新发明的药物。

IF 1.1

Journal of the Royal College of Physicians of Edinburgh Pub Date : 2025-03-01 Epub Date: 2025-01-10 DOI: 10.1177/14782715241312256

Kushagra Gupta, Vinod Ravindran

{"title":"Low-dose methotrexate in Rheumatology: A reinvented drug.","authors":"Kushagra Gupta, Vinod Ravindran","doi":"10.1177/14782715241312256","DOIUrl":"10.1177/14782715241312256","url":null,"abstract":"Low-dose methotrexate (LD-MTX) is the anchor drug used in the treatment of various rheumatological illnesses. There are a lot of misconceptions associated with the long-term use of MTX in the minds of practitioners. The origin of most of these myths stems from the ill effects associated with high-dose MTX used in cancer chemotherapy. In this review, we have summarised and discussed the latest data regarding the safety of LD-MTX. The current evidence underscores the safety of LD-MTX. It is not associated with liver and lung fibrosis as previously thought. Other major concerns such as bone marrow suppression and increased risk of infection are rare with chronic LD-MTX therapy. Hypersensitivity pneumonitis is a rare acute lung toxicity associated with MTX intake, it does not cause interstitial lung disease and in fact, may be protective against it. There is a slight concern about the increased risk of skin malignancy associated with MTX intake; however, association with no other malignancy has been found. It has taken many decades for researchers to clear the various preconceptions associated with MTX. It is time for the academic community to embrace LD-MTX as a new, separate and reinvented drug.","PeriodicalId":46606,"journal":{"name":"Journal of the Royal College of Physicians of Edinburgh","volume":" ","pages":"59-68"},"PeriodicalIF":1.1,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142956674","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0